Abiopharma

🔍 Ditillo David (Executive)

Company: Corebridge Financial, Inc. (CRBG)

Report Date: 2026-08-06

Detailed Transactions and Holdings:

• Acquired 3,914 shares of Common Stock at $20.3 per share (Direct)
  Date: 2026-08-06 | Code: M | equity_swap_involved: 0 | shares_owned_after: 123,567.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 12,414 shares of Common Stock at $34.0 per share (Direct)
  Date: 2026-08-06 | Code: S | equity_swap_involved: 0 | shares_owned_after: 111,153.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 3,914 shares of Options (Rights to Buy) at $20.3 per share (Derivative)
  Date: 2026-08-06 | Code: M | Expires: 2033-02-21 | equity_swap_involved: 0 | shares_owned_after: 18,914.00 | transaction_form_type: 4 | Footnotes: F2, F2

Footnotes:

• F1: Includes 40,342 restricted stock units, each of which represents a contingent right to receive one share of common stock of the Issuer.
• F2: Reflects employee stock options under CRBG's 2022 Omnibus Incentive Plan exempt under Rule 16b-3. The options vest ratably over three years from the grant date.